Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose naloxone added to ropivacaine for supraclavicular brachial plexus block
ChiCTR-IPR-17011219Phase 4Not yet recruiting
- Sponsor
- Department of Anesthesiology, Lanzhou University Second Hospital
- Start
- May 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of naloxone and ropivacaine in None (2 arms), sponsored by Department of Anesthesiology, Lanzhou University Second Hospital. Primary endpoint: Duration of sensory block. Planned start May 2017; status: not yet recruiting.
02
Drugs
naloxoneropivacaine
Beyond the preview
Go deeper on ChiCTR-IPR-17011219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011219.